Tissue Characterization With Hyperspectral Imaging (HSI)

NCT ID: NCT04230603

Last Updated: 2020-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-06

Study Completion Date

2022-06-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hyperspectral Imaging (HSI) is a contact free method to analyse the from the tissue reflected light in the range of 500-1000nm. Aim of the study is to identify special reflex patterns to identify special tissue

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This HSI-camera provides hyperspectral images with a high spectral resolution (5 nm) in the visible and near infrared range (500-1000 nm). A RGB image and 4 false color images that represent physiologic parameters are intraoperatively provided by an analysis software. But after the procedure all spectral datasets could be investigated. To analyse and differentiate the different tissues, a catalog database is needed of all tissues including Tumors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tissue Perfusion Tumor Inflammation Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hyperspectral imaging

diagnostic hyperspectral imaging of the human tissue an correlation with local blood parameters and local pathological examination

Group Type EXPERIMENTAL

Lactate acid measurement

Intervention Type DIAGNOSTIC_TEST

At the marked regions of the specimen, a lactate acid measurement was performed.

pathological examination

Intervention Type DIAGNOSTIC_TEST

At the marked regions of the specimen, the pathological examination was performed.

Hyperspectral imaging

Intervention Type PROCEDURE

Photos were taken with the hyperspectral camera of the human tissue

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lactate acid measurement

At the marked regions of the specimen, a lactate acid measurement was performed.

Intervention Type DIAGNOSTIC_TEST

pathological examination

At the marked regions of the specimen, the pathological examination was performed.

Intervention Type DIAGNOSTIC_TEST

Hyperspectral imaging

Photos were taken with the hyperspectral camera of the human tissue

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Marking of the target region (Suture/Clip/ink)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with surgical procedure

Exclusion Criteria

* inability to consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Leipzig

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Boris Jansen-Winkeln

Boris Jansen-Winkeln

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ines Gockel, MD, Prof.

Role: STUDY_DIRECTOR

University of Leipzig

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsklinikum Leipzig - AöR

Leipzig, Saxony, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Boris Jansen-Winkeln, MD, PD

Role: CONTACT

+49-314-97 ext. 17200

Ines Gockel, MD, Prof.

Role: CONTACT

+49-314-97 ext. 17200

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Boris Jansen-Winkeln, MD, PD

Role: primary

+49-341-97- ext. 17200

Ines Gockel, MD, Prof.

Role: backup

+49-341-97- ext. 17200

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201905

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ga-68 Dolacga PET Scan in HCC Under RFA
NCT06792097 NOT_YET_RECRUITING
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828 UNKNOWN EARLY_PHASE1
HCC Innervation Assessment
NCT06886763 ACTIVE_NOT_RECRUITING
Identification of Hepatic Lesions
NCT00307866 COMPLETED PHASE3